Manchester Metropolitan University's Research Repository

    Items where Author is "Hakimi, Zalmai"

    Up a level
    Export as [feed] Atom [feed] RSS
    Group by: Item Type | No Grouping
    Jump to: Article | Thesis
    Number of items: 5.


    Gebrye, Tadesse ORCID logoORCID: https://orcid.org/0000-0001-7976-2013, Fatoye, Francis ORCID logoORCID: https://orcid.org/0000-0002-3502-3953, Mbada, Chidozie ORCID logoORCID: https://orcid.org/0000-0003-3666-7432 and Hakimi, Zalmai (2023) A scoping review on quality assessment tools used in systematic reviews and meta-analysis of real world studies. Rheumatology International. ISSN 0172-8172

    (2023) Cost‐effectiveness of recombinant factor VIII Fc versus emicizumab for prophylaxis in adults and adolescents with haemophilia A without inhibitors in the UK. European Journal of Haematology, 110 (3). pp. 262-270. ISSN 0902-4441

    (2022) Cost-minimization analysis of recombinant factor VIII Fc versus emicizumab for treating patients with hemophilia A without inhibitors in Europe. Journal of Medical Economics, 25 (1). pp. 1068-1075. ISSN 1369-6998

    Nazir, Jameel, Hakimi, Zalmai, Guelfucci, Florent, Khemiri, Amine, Fatoye, Francis, Blázquez, Ana María Mora and González, Marta Hernández (2018) A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain. BMC Urology, 18 (1). ISSN 1471-2490


    Hakimi, Zalmai (2022) Assessment of health-related quality of life and patient preferences for treatments of overactive bladder. Doctoral thesis (PhD), Manchester Metropolitan University.

    This list was generated on Sun Mar 3 04:58:08 2024 GMT.